Pozen Sues Alphapharm, Mylan Over Generic Treximet
The suit, filed Friday in the U.S. District Court for the Eastern District of Texas, is the second Pozen has filed regarding planned generic Treximet. The company sued Par Pharmaceutical Inc. in the same court in November.
According to the suit, Australia-based Alphapharm, a wholly owned subsidiary of Pennsylvania-based Mylan, sent a...
Already a subscriber? Click here to login